Negative selection and autoimmunity

Current Opinion in Immunology

Volumn 15, Issue 6, 2003, Pages 668-676

  Ohashi, Pamela S ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AUTOIMMUNE REGULATOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNITY; CELL SELECTION; CELL SURVIVAL; MODEL; NONHUMAN; REVIEW; T LYMPHOCYTE; THYMOCYTE; THYMUS;

EID: 0242491039     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2003.09.013     Document Type: Review

References (98)

1. Starr T.K., Jameson S.C., Hogquist K.A. Positive and negative selection of T cells. Annu. Rev. Immunol. 21:2003;139-176.
2. Werlen G., Hausmann B., Naeher D., Palmer E. Signaling life and death in the thymus: timing is everything. Science. 299:2003;1859-1863.
3. + thymocytes. Nature. 333:1988;742-746.
4. Sha W.C., Nelson C.A., Newberry R.D., Kranz D.M., Russell J.H., Loh D.Y. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature. 336:1988;73-76.
5. White J., Herman A., Pullen A.M., Kubo R., Kappler J.W., Marrack P. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 56:1989;27-35.
6. Ohashi P.S., Pircher H., Bürki K., Zinkernagel R.M., Hengartner H. Distinct sequence of negative or positive selection implied by thymocyte T cell receptor densities. Nature. 346:1990;861-863.
7. Pircher H., Hoffmann Rohrer U., Moskophidis D., Zinkernagel R.M., Hengartner H. Lower receptor avidity required for thymic clonal deletion than for effector T cell function. Nature. 351:1991;482-485.
8. Laufer T.M., DeKoning J., Markowitz J.S., Lo D., Glimcher L.H. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature. 383:1996;81-85.
9. McGargill M.A., Derbinski J.M., Hogquist K.A. Receptor editing in developing T cells. Nat. Immunol. 1:2000;336-341.
10. Buch T., Rieux-Laucat F., Förster I., Rajewsky K. Failure of HY-specific thymocytes to escape negative selection by receptor editing. Immunity. 16:2002;707-718.
11. Rivera R.R., Johns C.P., Quan J., Johnson R.S., Murre C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, ld3. Immunity. 12:2000;17-26.
12. Saijo K., Park S.Y., Ishida Y., Arase H., Saito T. Crucial role of Jak3 in negative selection of self-reactive T cells. J. Exp. Med. 185:1997;351-356.
13. Ludviksson B.R., Ehrhardt R.O., Strober W. Role of IL-12 in intrathymic negative selection. J. Immunol. 163:1999;4349-4359.
14. Baird A.M., Gerstein R.M., Berg L.J. The role of cytokine receptor signaling in lymphocyte development. Curr. Opin. Immunol. 11:1999;157-166.
15. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell. 89:1997;1033-1041.
16. -/- mice. Cell. 89:1997;1011-1019.
17. + T cells. J. Exp. Med. 197:2003;475-487.
18. Brewer J.A., Kanagawa O., Sleckman B.P., Muglia L.J. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J. Immunol. 169:2002;1837-1843 A clear and excellent study, using glucocorticoid receptor knockout thymocytes, showing that anti-TCR treatment in vivo is not a model for negative selection.
19. Lerner A., Clayton L.K., Mizoguchi E., Ghendler Y., van Ewijk W., Koyasu S., Bhan A.K., Reinherz E.L. Cross-linking of T-cell receptors on double-positive thymocytes induces a cytokine-mediated stromal activation process linked to cell death. EMBO J. 15:1996;5876-5887.
20. Webb S.R., Sprent J. Tolerogenicity of thymic epithelium. Eur. J. Immunol. 20:1990;2525-2528.
21. Speiser D.E., Pircher H., Ohashi P.S., Kyburz D., Hengartner H., Zinkernagel R.M. Clonal deletion induced by either thymic epithelium or lymphohemopoietic cells at different stages of class I restricted T cell ontogeny. J. Exp. Med. 175:1992;1277-1283.
22. Pietropaolo M., Giannoukakis N., Trucco M. Cellular environment and freedom of gene expression. Nat. Immunol. 3:2002;335-336.
23. Jolicoeur C., Hanahan D., Smith K.M. T-cell tolerance toward a transgenic β-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc. Natl. Acad. Sci. U.S.A. 91:1994;6707-6711.
24. Smith K.M., Olson D.C., Hirose R., Hanahan D. Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance. Int. Immunol. 9:1997;1355-1365.
25. Derbinski J., Schulte A., Kyewski B., Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2:2001;1032-1039.
26. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J.E., Lalioti M.D., Mullis P.E., Antonarakis S.E., et al. Positional cloning of the APECED gene. Nat. Genet. 17:1997;393-398.
27. The Finnish-German APECED Consortium: An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997, 17:399-403.
28. Björses P., Aaltonen J., Horelli-Kuitunen N., Yaspo M.L., Peltonen L. Gene defect behind APECED: a new clue to autoimmunity. Hum. Mol. Genet. 7:1998;1547-1553.
29. Peterson P., Nagamine K., Scott H., Heino M., Kudoh J., Shimizu N., Antonarakis S.E., Krohn K.J.E. APECED: a monogenic autoimmune disease providing new clues to self-tolerance. Immunol. Today. 19:1998;384-386.
30. Ramsey C., Winqvist O., Puhakka L., Halonen M., Moro A., Kämpe O., Eskelin P., Pelto-Huikko M., Peltonen L. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 11:2002;397-409 This is the first report to describe the phenotype of Aire-deficient mice.
31. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science. 298:2002;1395-1401 This is the first report to describe the phenotype of Aire-deficient mice, with interesting data showing that Aire regulates the expression of a variety of tissue-specific genes in MECs. This gives a clear insight into the tolerance defects in these animals and correlates well with the reported autoimmune disease progression.
32. Liston A., Lesage S., Wilson J., Peltonen L., Goodnow C.C. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4:2003;350-354 This is the first study to show that Aire plays a direct role in thymic tolerance. The authors used a double transgenic model of mice bearing a TCR transgene specific for HEL and another transgene, InsHEL, that expressed HEL in the β-islets and systemically.
33. Zhou T., Bluethmann H., Eldridge J., Brockhaus M., Berry K., Mountz J.D. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. J. Immunol. 147:1991;466-474.
34. Singer G.G., Abbas A.K. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:1994;365-371.
35. Foy T.M., Page D.M., Waldschmidt T.J., Schoneveld A., Laman J.D., Masters S.R., Tygrett L., Ledbetter J.A., Aruffo A., Claassen E., et al. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182:1995;1377-1388.
36. Amakawa R., Hakem A., Kündig T.M., Matsuyama T., Simard J.J.L., Timms E., Wakeham A., Mittruecker H.W., Griesser H., Takimoto H., et al. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell. 84:1996;551-562.
37. Page D.M., Roberts E.M., Peschon J.J., Hedrick S.M. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 160:1998;120-133.
38. Kishimoto H., Surh C.D., Sprent J. A role for Fas in negative selection of thymocytes in vivo. J. Exp. Med. 187:1998;1427-1438.
39. DeYoung A.L., Duramad O., Winoto A. The TNF receptor family member CD30 is not essential for negative selection. J. Immunol. 165:2000;6170-6173.
40. Wang E.C.Y., Thern A., Denzel A., Kitson J., Farrow S.N., Owen M.J. DR3 regulates negative selection during thymocyte development. Mol. Cell Biol. 21:2001;3451-3461.
41. Wang J., Chun T., Lo J.C., Wu Q., Wang Y., Foster A., Roca K., Chen M., Tamada K., Chen L., et al. The critical role of LIGHT, a TNF family member, in T cell development. J. Immunol. 167:2001;5099-5105.
42. Wang J., Fu Y.-X. LIGHT (a cellular ligand for Herpes virus entry mediator and lymphotoxin receptor)-mediated thymocyte deletion is dependent on the interaction between TCR and MHC/self-peptide. J. Immunol. 170:2003;3986-3993.
43. -/- thymocytes were shown to be resistant to both anti-CD3- and superantigen-induced death.
44. Walsh C.M., Wen B.G., Chinnaiyan A.M., O'Rourke K., Dixit V.M., Hedrick S.M. A role for FADD in T cell activation and development. Immunity. 8:1998;439-449.
45. Newton K., Harris A.W., Bath M.L., Smith K.G.C., Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17:1998;706-718.
46. Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P.Y.B., Berry D.M., Tamblyn L., Shehabeldin A., Migon E., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17:2003;883-895.
47. Kuida K., Zheng T.S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:1996;368-372.
48. Alam A., Braun M.Y., Hartgers F., Lesage S., Cohen L., Hugo P., Denis F., Sekaly R.P. Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus. J. Exp. Med. 186:1997;1503-1512.
49. Woo M., Hakem R., Soengas M.S., Duncan G.S., Shahinian A., Kägi D., Hakem A., McCurrach M., Khoo W., Kaufman S.A., et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:1998;806-819.
50. Izquierdo M., Grandien A., Criado L.M., Robles S., Leonardo E., Albar J.P., González de Buitrago G., Martínez A.C. Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor. EMBO J. 18:1999;156-166.
51. Doerfler P., Forbush K.A., Perlmutter R.M. Caspase enzyme activity is not essential for apoptosis during thymocyte development. J. Immunol. 164:2000;4071-4079.
52. Conte D., Liston P., Wong J.W., Wright K.E., Korneluk R.G. Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5049-5054.
53. Hara H., Takeda A., Takeuchi M., Wakeham A.C., Itié A., Sasaki M., Mak T.W., Yoshimura A., Nomoto K., Yoshida H. The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. J. Immunol. 168:2002;2288-2295.
54. Matsuki Y., Zhang H., Hsu H.-C., Yang P.-A., Zhou T., Dodd C.H., Cecconi F., Gruss P., Tadakuma T., Mountz J.D. Different role of Apaf-1 in positive selection, negative selection and death by neglect in foetal thymic organ culture. Scand. J. Immunol. 56:2002;174-184.
55. Buhlmann J.E., Elkin S.K., Sharpe A.H. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection. J. Immunol. 170:2003;5421-5428.
56. Bouillet P., Purton J.F., Godfrey D.I., Zhang L.-C., Coultas L., Puthalakath H., Pellegrini M., Cory S., Adams J.M., Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:2002;922-926 This study shows that Bim influences thymocyte survival and is upregulated upon TCR ligation of thymocytes.
57. Bouillet P., Metcalf D., Huang D.C.S., Tarlinton D.M., Kay T.W.H., Köntgen F., Adams J.M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1999;1735-1738.
58. Newton K., Strasser A. Cell death control in lymphocytes. Adv. Immunol. 76:2001;179-226.
59. Zong W.X., Lindsten T., Ross A.J., MacGregor G.R., Thompson C.B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15:2001;1481-1486.
60. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8:2001;705-711.
61. Rathmell J.C., Lindsten T., Zong W.-X., Cinalli R.M., Thompson C.B. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat. Immunol. 3:2002;932-939 This paper shows that Bak and Bax contribute to thymocyte death.
62. Brady H.J.M., Gil-Gomez G., Kirberg J., Berns A.J.M. Baxα perturbs T cell development and affects cell cycle entry of T cells. EMBO J. 15:1996;6991-7001.
63. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell. 6:2000;1389-1399.
64. L levels, and NF-κB activation in vivo. J. Exp. Med. 191:2000;1721-1733.
65. Suzuki A., Yamaguchi M.T., Ohteki T., Sasaki T., Kaisho T., Kimura Y., Yoshida R., Wakeham A., Higuchi T., Fukumoto M., et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity. 14:2001;523-534.
66. Khaled A.R., Li W.Q., Huang J., Fry T.J., Khaled A.S., Mackall C.L., Muegge K., Young H.A., Durum S.K. Bax deficiency partially corrects interleukin-7 receptor α deficiency. Immunity. 17:2002;561-573.
67. Pallard C., Stegmann A.P.A., van Kleffens T., Smart F., Venkitaraman A., Spits H. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity. 10:1999;525-535.
68. Karin M., Lin A. NF-κB at the crossroads of life and death. Nat. Immunol. 3:2002;221-227.
69. Fiorini E., Schmitz I., Marissen W.E., Osborm S.L., Touma M., Sasada T., Reche P.A., Tibaldi E.V., Hussey R.E., Kruisbeek A.M., et al. Peptide-induced negative selection of thymocytes activates transcription of an NF-κB inhibitor. Mol. Cell. 9:2002;637-648 These exciting studies show that expression of a newly identified IκB family member is induced upon signals for thymocyte negative selection.
70. Strasser A., Grumont R.J., Stanley M.L., Gerondakis S. A transcriptional regulator Rel is essential for antigen receptor-mediated stimulation of mature T cells but dispensable for positive and negative selection of thymocytes and T cell apoptosis. Eur. J. Immunol. 29:1999;928-935.
71. Weih F., Carrasco D., Durham S.K., Barton D.S., Rizzo C.A., Rysek R.-P., Lira S.A., Bravo R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell. 80:1995;331-340.
72. Guerin S., Baron M.-L., Valero R., Herrant M., Auberger P., Naquet P. RelB reduces thymocyte apoptosis and regulates terminal thymocyte maturation. Eur. J. Immunol. 32:2002;1-9.
73. Burkly L., Hession C., Ogata L., Reilly C., Marconi L.A., Olson D., Tizard R., Cate R., Lo D. Expression of relB is required for the development of thymic medulla and dendtritic cells. Nature. 373:1995;531-536.
74. + dentritic cells. Immunity. 9:1998;839-847.
75. + thymocytes. J. Exp. Med. 188:1998;1817-1830.
76. Sugawara T., Moriguchi T., Nishida E., Takahama Y. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity. 9:1998;565-574.
77. Gong Q., Cheng A.M., Akk A.M., Alberola-Ila J., Gong G., Pawson T., Chan A.C. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nat. Immunol. 2:2001;29-36.
78. 2-terminal kinase. Mol. Cell Biol. 22:2002;4929-4942.
79. -/- thymocytes remain as sensitive as control mice.
80. Bain G., Cravatt C.B., Loomans C., Alberola-Ila J., Hedrick S.M., Murre C. Regulation of the helix-loop-helix proteins, E2A and Id3, by the ras-ERK MAPK cascade. Nat. Immunol. 2:2001;165-171.
81. Werlen G., Hausmann B., Palmer E. A motif in the αβ T-cell receptor controls positive selection by modulating ERK activity. Nature. 406:2000;422-426.
82. Mariathasan S., Zakarian A., Bouchard D., Ohashi P.S. Duration and strength of extracellular signal-regulated kinase signals are altered during positive versus negative thymocyte selection. J. Immunol. 167:2001;4966-4973.
83. Mariathasan S., Ho S.S.N., Zakarian A., Ohashi P.S. Degree of ERK activation influences both positive and negative thymocyte selection. Eur. J. Immunol. 30:2000;1060-1068.
84. + thymocytes. J. Immunol. 164:2000;2326-2337.
85. Liu Z.-G., Smith S.W., McLaughlin K.A., Schwartz L.M., Osborne B.A. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature. 281:1994;284.
86. Woronicz J.D., Calnan B., Ngo V., Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature. 367:1994;277-281.
87. Calnan B.J., Szychowski S., Chan F.K.M., Cado D., Winoto A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity. 3:1995;273-282.
88. Zhou T., Cheng J., Yang Z., Liu C., Su X., Bluethmann H., Mountz J.D. Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J. Exp. Med. 183:1996;1879-1892.
89. Dequiedt F., Kasler H., Fischle W., Kiermer V., Weinstein M., Herndier B.G., Verdin E. HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity. 18:2003;687-698 Dequiedt, et al. show here that a histone deacetylase is expressed at the DP stage of thymocyte development, and plays a role in TCR-mediated death.
90. Kishimoto H., Sprent J. A defect in central tolerance in NOD mice. Nat. Immunol. 2:2001;1025-1031.
91. Lesage S., Hartley S.B., Akkaraju S., Wilson J., Townsend M., Goodnow C.C. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J. Exp. Med. 196:2002;1175-1188.
92. McGargill M.A., Mayerova D., Stefanski H.E., Koehn B., Parke E.A., Jameson S.C., Panoskaltsis-Mortari A., Hogquist K.A. A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J. Immunol. 169:2002;2141-2147.
93. Lenardo M.J., Chan F.K.M., Hornung F., McFarland H., Siegel R., Wang J., Zheng L. Mature T Lymphocyte Apoptosis - immune regulation in a dynamic and unpredictable environment. Annu. Rev. Immunol. 17:1999;221-253.
94. Ohashi P.S. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat. Rev. Immunol. 2:2002;427-438.
95. Shortman K., Egerton M., Spangrude G.J., Scollay R. The generation and fate of thymocytes. Semin. Immunol. 2:1990;3-12.
96. Trigueros C., Hozumi K., Silva-Santos B., Bruno L., Hayday A.C., Owen M.J., Pennington D.J. Pre-TCR signaling regulates IL-7 receptor alpha expression promoting thymocyte survival at the transition from the double-negative to double-positive stage. Eur. J. Immunol. 33:2003;1968-1977.
97. Villunger A., Marsden V.S., Strasser A. Efficient T cell receptor-mediated apoptosis in nonobese diabetic mouse thymocytes. Nat. Immunol. 4:2003;717.
98. Cretney E., Uldrich A.P., Berzins S.P., Strasser A., Godfrey D.I., Smyth M.J. Normal thymocyte negative selection in TRAIL-deficient mice. J. Exp. Med. 198:2003;491-496.